Gulmira Gulmira Tussupbekova

Dr. Gulmira Gulmira Tussupbekova


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2023 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
Javad Sharifi-RadJavad Sharifi-Rad
Javad Sharifi-Rad
Veronique SeidelVeronique Seidel
Veronique Seidel
Izabela MichalakIzabela Michalak
Izabela Michalak
Margalida Monserrat-MesquidaMargalida Monserrat-Mesquida
Margalida Monserrat-Mesquida
Antoni SuredaAntoni Sureda
Antoni Sureda
William C. ChoWilliam C. Cho
William C. Cho
Cancer is a leading cause of death worldwide and involves an oxidative stress mechanism. The transcription factor Nrf2 has a crucial role in cytoprotective response against oxidative stress, including cancer growth and progression and therapy resistance. For this reason, inhibitors of Nrf2 are new targets to be studied. Traditional plant-based remedies rich in phytochemicals have been used against human cancers and phenolic compounds are known for their chemopreventive properties. This comprehensive review offers an updated review of the role of phenolic compounds as anticancer agents due to their action on Nrf2 inhibition. In addition, the role of naturally-occurring bioactive anticancer agents are covered in the clinical applications of polyphenols as Nrf2 inhibitors.

1 January 2025 in Engineered Science
Verified
Journal Article
Open access
PDF file
GTGulmira Gulmira Tussupbekova
Gulmira Gulmira Tussupbekova
A comprehensive review revealing how Kv7 channels' structure and regulation influence excitability, offering novel insights into channelopathy pathogenesis and therapy.

Verified
Journal Article
Open access
PDF file
Valery P. ZinchenkoValery P. Zinchenko
Valery P. Zinchenko
AKArtem M. Kosenkov
Artem M. Kosenkov
SASergeev Alex
Sergeev Alex
ФТФëдор Тюрин
Фëдор Тюрин
ETEgor Turovsky
Egor Turovsky
STSultan T. Tuleukhanov
Sultan T. Tuleukhanov
Excitable neurons are intrinsically capable of firing action potentials (AP), yet a state of hyperexcitability is prevented in the central nervous system by powerful GABAergic inhibition. For this inhibition to be effective, it must occur before excitatory signals can initiate runaway activity, implying the existence of a proactive control system. To test for such proactive inhibition, we used Ca2+ imaging and patch-clamp recording to measure how hippocampal neurons respond to depolarization and glutamatergic agonists. In mature hippocampal cultures (14 days in vitro (DIV)) and acute brain slices from two-month-old rats, neurons exhibited non-simultaneous responses to various excitatory stimuli, including KCl, NH4Cl, forskolin, domoic acid, and glutamate. We observed that the Ca2+ rise occurred significantly earlier in GABAergic neurons than in glutamatergic neurons. This delay in glutamatergic neurons was abolished by GABA(A) receptor inhibitors, suggesting a mechanism of preliminary γ-aminobutyric acid (GABA) release. We further found that these early-responding GABAergic neurons express calcium-permeable kainate and AMPA receptors (CP-KARs and CP-AMPARs). Application of domoic acid induced an immediate Ca2+ increase in neurons expressing these receptors, but a delayed response in others. Crucially, when domoic acid was applied in the presence of the AMPA receptor inhibitors NBQX or GYKI-52466, the response delay in glutamatergic neurons was significantly prolonged. This confirms that CP-KARs on GABAergic neurons are responsible for the delayed excitation of glutamatergic neurons. In hippocampal slices from two-month-old rats, depolarization with 50 mM KCl revealed two distinct neuronal populations based on their calcium dynamics: a majority group (presumably glutamatergic) exhibited fluctuating Ca2+ signals, while a minority (presumably GABAergic) showed a steady, advancing increase in [Ca2+]i. This distinction was reinforced by the application of domoic acid. The “advancing-response” neurons reacted to domoic acid with a similar prompt increase, whereas the “fluctuating-response” neurons displayed an even more delayed and fluctuating reaction (80 s delay). Therefore, we identify a subgroup of hippocampal neurons—in both slices and cultures—that respond to depolarization and domoic acid with an early [Ca2+]i signal. Consistent with our data from cultures, we conclude these early-responding neurons are GABAergic. Their early GABA release directly explains the delayed Ca2+ response observed in glutamatergic neurons. We propose that this proactive mechanism, mediated by CP-KARs on GABAergic neurons, is a primary means of protecting the network from hyperexcitation. Furthermore, the activity of these CP-KAR-expressing neurons is itself regulated by GABAergic neurons containing CP-AMPARs.

7 November 2026 in Life
Verified
Journal Article
Open access
PDF file
NZNazgul Zhaparkulova
Nazgul Zhaparkulova
GZGulzhan Zhamanbayeva
Gulzhan Zhamanbayeva
ZZZhuldyz Zhaksybay
Zhuldyz Zhaksybay
MMMolsadykkyzy Madina
Molsadykkyzy Madina
AAAkbota Amankeldi
Akbota Amankeldi
Ilya DigelIlya Digel
Ilya Digel
Gestational diabetes mellitus (GDM) is a heterogeneous metabolic disorder in which maternal dysmetabolism interacts with placental adaptation and fetal development. Plant-derived bioactive compounds have attracted interest because they modulate metabolic, inflammatory, redox, mitochondrial, nutrient-sensing, and vascular pathways implicated in GDM; however, mechanistic activity alone does not establish therapeutic suitability during pregnancy. This critical narrative review evaluates selected phytochemicals using a placenta-centered translational perspective that distinguishes evidence from women with GDM, human placental and pregnancy-associated tissues, pregnancy-specific animal models, and mechanistic cellular systems. Human placental studies demonstrate substantial heterogeneity in insulin signaling, mitochondrial function, oxidative stress, inflammation, nutrient transport, and angiogenic regulation, emphasizing that altered pathways may represent pathological, compensatory, or adaptive responses. Among the compounds reviewed, EGCG has the most direct clinical treatment evidence, whereas naringenin shows particularly strong disease-specific placental mechanistic alignment. Quercetin and mangiferin have substantial pregnancy-specific preclinical support, while resveratrol and berberine illustrate how fetal or developmental concerns can limit translation despite promising metabolic effects. Overall, no isolated phytochemical currently combines replicated clinical efficacy, defined maternal–fetal pharmacokinetics, placental relevance, and adequate developmental safety. Future translation requires integrated evaluation across the maternal–placental–fetal unit.

12 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Valery P. ZinchenkoValery P. Zinchenko
Valery P. Zinchenko
AKA. M. Kosenkov
A. M. Kosenkov
SASergeev Alex
Sergeev Alex
FTF. V. Tyurin
F. V. Tyurin
ETEgor Turovsky
Egor Turovsky
STS. T. Tuleukhanov
S. T. Tuleukhanov
Excitable neurons are intrinsically capable of firing action potentials, yet a state of hyperexcitability is prevented in the central nervous system by powerful GABAergic inhibition. For this inhibition to be effective, it must occur before excitatory signals can initiate runaway activity, implying the existence of a proactive control system. To test for such proactive inhibition, we used Ca²⁺ imaging and patch-clamp recording to measure how hippocampal neurons respond to depolarization and glutamatergic agonists. In mature hippocampal cultures (14 DIV) and acute brain slices from two-month-old rats, neurons exhibited non-simultaneous responses to various excitatory stimuli, including KCl, NH4Cl, forskolin, domoic acid, and glutamate. We observed that the Ca²⁺ rise occurred significantly earlier in GABAergic neurons than in glutamatergic neurons. This delay in glutamatergic neurons was abolished by GABA(A) receptor inhibitors, suggesting a mechanism of preliminary GABA release. We further found that these early-responding GABAergic neurons express calcium-permeable kainate and AMPA receptors (CP-KARs and CP-AMPARs). Application of domoic acid induced an immediate Ca²⁺ increase in neurons expressing these receptors, but a delayed response in others. Crucially, when domoic acid was applied in the presence of the AMPA receptor inhibitors NBQX or GYKI-52466, the response delay in glutamatergic neurons was significantly prolonged. This confirms that CP-KARs on GABAergic neurons are responsible for the delayed excitation of glutamatergic neurons. In hippocampal slices from two-month-old rats, depolarization with 50 mM KCl revealed two distinct neuronal populations based on their calcium dynamics: a majority group (presumably glutamatergic) exhibited fluctuating Ca²⁺ signals, while a minority (presumably GABAergic) showed a steady, advancing increase in [Ca²⁺]i. This distinction was reinforced by the application of domoic acid. The "advancing-response" neurons reacted to domoic acid with a similar prompt increase, whereas the "fluctuating-response" neurons displayed an even more delayed and fluctuating reaction (80 s delay). Therefore, we identify a subgroup of hippocampal neurons—in both slices and cultures—that respond to depolarization and domoic acid with an early [Ca²⁺]i signal. Consistent with our data from cultures, we conclude these early-responding neurons are GABAergic. Their early GABA release directly explains the delayed Ca²⁺ response observed in glutamatergic neurons. We propose that this proactive mechanism, mediated by CP-KARs on GABAergic neurons, is a primary means of protecting the network from hyperexcitation. Furthermore, the activity of these CP-KAR-expressing neurons is itself regulated by GABAergic neurons containing CP-AMPARs.